Clinical Trial Update: Intermittent vs. Continuous HAART to Treat Chronic HIV Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intermittent versus continuous HAART for chronic HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HAART (Highly Active Antiretroviral Therapy) (Highly Active Antiretroviral Therapy)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 3 | Status: COMPLETED